Suppr超能文献

通过改变肠道微生物群控制狼疮肾炎。

Control of lupus nephritis by changes of gut microbiota.

机构信息

Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.

Department of Civil and Environmental Engineering, Virginia Tech, Blacksburg, VA, USA.

出版信息

Microbiome. 2017 Jul 11;5(1):73. doi: 10.1186/s40168-017-0300-8.

Abstract

BACKGROUND

Systemic lupus erythematosus, characterized by persistent inflammation, is a complex autoimmune disorder with no known cure. Immunosuppressants used in treatment put patients at a higher risk of infections. New knowledge of disease modulators, such as symbiotic bacteria, can enable fine-tuning of parts of the immune system, rather than suppressing it altogether.

RESULTS

Dysbiosis of gut microbiota promotes autoimmune disorders that damage extraintestinal organs. Here we report a role of gut microbiota in the pathogenesis of renal dysfunction in lupus. Using a classical model of lupus nephritis, MRL/lpr, we found a marked depletion of Lactobacillales in the gut microbiota. Increasing Lactobacillales in the gut improved renal function of these mice and prolonged their survival. We used a mixture of 5 Lactobacillus strains (Lactobacillus oris, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus johnsonii, and Lactobacillus gasseri), but L. reuteri and an uncultured Lactobacillus sp. accounted for most of the observed effects. Further studies revealed that MRL/lpr mice possessed a "leaky" gut, which was reversed by increased Lactobacillus colonization. Lactobacillus treatment contributed to an anti-inflammatory environment by decreasing IL-6 and increasing IL-10 production in the gut. In the circulation, Lactobacillus treatment increased IL-10 and decreased IgG2a that is considered to be a major immune deposit in the kidney of MRL/lpr mice. Inside the kidney, Lactobacillus treatment also skewed the Treg-Th17 balance towards a Treg phenotype. These beneficial effects were present in female and castrated male mice, but not in intact males, suggesting that the gut microbiota controls lupus nephritis in a sex hormone-dependent manner.

CONCLUSIONS

This work demonstrates essential mechanisms on how changes of the gut microbiota regulate lupus-associated immune responses in mice. Future studies are warranted to determine if these results can be replicated in human subjects.

摘要

背景

系统性红斑狼疮(SLE)以持续性炎症为特征,是一种复杂的自身免疫性疾病,目前尚无已知的治愈方法。治疗中使用的免疫抑制剂会使患者面临更高的感染风险。对疾病调节剂(如共生细菌)的新认识可以实现对免疫系统部分的精细调节,而不是完全抑制它。

结果

肠道微生物群落失调会促进自身免疫性疾病,从而损害肠道外器官。在这里,我们报告了肠道微生物群在狼疮性肾功能障碍发病机制中的作用。我们使用狼疮肾炎的经典模型 MRL/lpr,发现肠道微生物群中乳杆菌科明显减少。增加肠道中的乳杆菌科可改善这些小鼠的肾功能并延长其存活时间。我们使用了 5 种乳杆菌菌株(口腔乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、约氏乳杆菌和加氏乳杆菌)的混合物,但乳杆菌和一种未培养的乳杆菌属占了大部分观察到的效果。进一步的研究表明,MRL/lpr 小鼠的肠道通透性增加,而增加乳杆菌定植则可以逆转这种情况。乳杆菌治疗通过减少肠道中 IL-6 的产生和增加 IL-10 的产生,有助于形成抗炎环境。在循环中,乳杆菌治疗增加了 IL-10 并降低了 IgG2a,后者被认为是 MRL/lpr 小鼠肾脏中的主要免疫沉积物。在肾脏内,乳杆菌治疗也使 Treg-Th17 平衡向 Treg 表型倾斜。这些有益的影响在雌性和去势雄性小鼠中存在,但在完整雄性小鼠中不存在,这表明肠道微生物群以依赖性激素的方式控制狼疮肾炎。

结论

这项工作证明了肠道微生物群如何调节小鼠狼疮相关免疫反应的重要机制。未来的研究需要确定这些结果是否可以在人类受试者中得到复制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/5505136/2643023a3f2f/40168_2017_300_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验